Clinical Trial Update: Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID [Phase 2]

View source ↗

Summary

Phase 2 trial update shows ensitrelvir being studied for viral persistence and inflammation in people with long COVID, with the study status listed as active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Ensitrelvir (ensitrelvir)

Snippet

Sponsor: Timothy Henrich | Conditions: Long COVID, Post Acute Sequelae of COVID-19 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-04-02